Latest Share Chat

Avacta Group Share News (AVCT)

Avacta Group Information

Buy AVCT Shares
Add AVCT to Watchlist
Add AVCT to Alert

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 48.00

Bid: 47.00

Ask: 49.00

Change: 2.25 (4.92%)

Spread: 2.00 (4.255%)

Open: 45.75

High: 48.50

Low: 45.75

Prev. Close: 45.75

Last checked at -

IN BRIEF: Avacta to sell Covid-19 test in UK in "coming days"

Mon, 10th May 2021 11:13

Avacta Group PLC - Yorkshire-based drug and diagnostic equipment developer - Submits declaration of conformity for rapid Covid-19 lateral flow test to the UK's Medicines & Healthcare Products Regulatory Agency. Expects registration of test to be confirmed in the coming days, before it is immediately placed on the market. The test has been shown to be more sensitive than lateral flow tests currently on the market, particularly for lower viral loads.

Current stock price: 266.88 pence, up 1.9% on Monday

Year-to-date change: more than doubled from 114.0p on December 31

By Ivan Edwards; ivanedwards@alliancenews.com

More News

16 Feb 2021 11:31

AIM WINNERS & LOSERS: Cornish Metals Jumps 40% On AIM Debut

16 Feb 2021 09:48

Avacta Shares Surge On Positive Data For Covid-19 Antigen Test

16 Feb 2021 09:38

Avacta upbeat on initial data for Covid-19 rapid test study

(Sharecast News) - Biotherapeutics and reagents developer Avacta Group has received the first data for its SARS-CoV-2 rapid antigen test from ongoing clinical studies in Europe and the UK, it announced on Tuesday.

8 Feb 2021 11:25

Avacta enters commercial partnership with Mologic

(Sharecast News) - Biotherapeutics developer Avacta Group has entered into a commercial partnership with Mologic, it announced on Monday, to accelerate to market its 'AffiDX' SARS-CoV-2 lateral flow rapid antigen test.

8 Feb 2021 10:46

AIM WINNERS & LOSERS: Bahamas Petroleum Sinks As Pulls Plug On Well

8 Feb 2021 09:37

Avacta Signs Agreement With Mologic For AffiDX Covid-19 Antigen Test

1 Feb 2021 14:37

TRADING UPDATES: Asiamet Hits Back At Shareholder; Hardide Raises Cash

1 Feb 2021 09:25

Avacta joint venture with Daewoong raises $7.3m in series A funding

(Sharecast News) - Biotherapeutics developer Avacta Group announced on Monday that its joint venture with Daewoong Pharmaceutical, AffyXell Therapeutics, has closed a series A venture capital investment of $7.3m (£5.32m) to further develop its pipeline of next generation cell and gene therapies.

28 Jan 2021 14:42

IN BRIEF: Avacta Lands Deal With Bruker To Assess SARS-CoV-2 Test

7 Jan 2021 13:51

IN BRIEF: Avacta Group Enters License Agreement With Point Biopharma

7 Jan 2021 08:58

Avacta enters licence agreement with Point Biopharma

(Sharecast News) - Cancer therapy and diagnostics developer Avacta Group has entered into a licence agreement with Point Biopharma, it announced on Thursday, to provide access to its 'preCISION' technology for the development of tumour-activated radiopharmaceuticals.

23 Dec 2020 19:50

UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost

23 Dec 2020 08:56

Avacta submits clinical trial application for 'AVA6000' prodrug

(Sharecast News) - Cancer therapy developer Avacta Group has submitted a clinical trial application in the UK for a phase 1 first-in-human open label dose-escalation and expansion study of its lead 'preCISION' prodrug, 'AVA6000', in patients with locally-advanced or metastatic selected solid tumours, it announced on Wednesday.

21 Dec 2020 18:10

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

21 Dec 2020 09:49

Avacta enters 'Affimer' licensing deal with Astrea Bioseparations

(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group has entered into a licensing agreement with Astrea Bioseparations, it announced on Monday, for the use of the 'Affimer' platform in affinity purification applications.

Latest Share Chat

Avacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Avacta to sell Covid-19 test in UK in "coming days"

Login to your account

Quickpicks are a member only feature

Login to your account